Ann Mekilo
Medical · Honesdale, PANPI 1760793715
Payments from drug & device makers
Across 136 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$459
- Daiichi Sankyo Inc.$356
- AbbVie$214
- Bayer$164
- GSK$152
- Pfizer$151
- plus $880 from 20 others
What the payments were for
- Food & beverage$2,377100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $459 |
| Daiichi Sankyo Inc. | 19 | $356 |
| AbbVie | 13 | $214 |
| Bayer | 8 | $164 |
| GSK | 9 | $152 |
| Pfizer | 9 | $151 |
| Amgen | 7 | $119 |
| Eisai Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Astellas Pharma US Inc | 5 | $81 |
| Myriad Women's Health, Inc. | 1 | $68 |
| Lilly USA, LLC | 4 | $67 |
| AstraZeneca(2 entities) | 4 | $65 |
| Nestle Healthcare Nutrition Inc. | 4 | $60 |
| Actelion Pharmaceuticals US, Inc. | 2 | $44 |
| Merck | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Phadia US Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Si-bone, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$2,377 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $6,893 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $582 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $533 |
| Fluoxetine Hcl | 20 | $445 |
| Metoprolol Succinate | 18 | $400 |
| Fluticasone Propionate | 12 | $387 |
| Atorvastatin Calcium | 14 | $315 |
| Gabapentin | 25 | $291 |
| CefuroximeCefuroxime Axetil | 14 | $258 |
| Azithromycin | 44 | $210 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $207 |
| Doxycycline Hyclate | 24 | $206 |
| Omeprazole | 22 | $197 |
| Lisinopril | 20 | $192 |
| Potassium Chloride | 16 | $190 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $151 | $6,89312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Honesdale
- Jacqueline KernaghanSpringfield$427K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.